Herbalife Receives “Buy” Rating from DA Davidson (HLF)
Herbalife (NYSE:HLF)‘s stock had its “buy” rating reaffirmed by stock analysts at DA Davidson in a report issued on Thursday, AmericanBankingNews.com reports. They currently have a $115.00 price objective on the stock. DA Davidson’s target price would suggest a potential upside of 46.12% from the stock’s previous close.
The analysts wrote, “The company has had two big-four audits, both with a clean bill of health. The second, by PwC, with particular attention and inquiry paid to allegations made by a now-infamous short seller,” the report said. “Perversely, the inquisition Herbalife has endured for the past year has made the company better with a few “raising the bar” policy tweaks on product returns and “lead generation.”
Shares of Herbalife (NYSE:HLF) traded up 0.97% on Thursday, hitting $79.46. 369,768 shares of the company’s stock traded hands. Herbalife has a 52-week low of $30.84 and a 52-week high of $81.75. The stock has a 50-day moving average of $72.72 and a 200-day moving average of $64.18. The company has a market cap of $8.026 billion and a P/E ratio of 16.64.
Herbalife (NYSE:HLF) last announced its earnings results on Wednesday, October 30th. The company reported $1.41 earnings per share for the quarter, beating the analysts’ consensus estimate of $1.14 by $0.27. The company had revenue of $1.20 billion for the quarter, compared to the consensus estimate of $1.20 billion. During the same quarter last year, the company posted $1.04 earnings per share. Herbalife’s revenue was up 19.3% compared to the same quarter last year.
HLF has been the subject of a number of other recent research reports. Analysts at S&P Equity Research downgraded shares of Herbalife to a “sell” rating in a research note to investors on Monday. Separately, analysts at Wedbush raised their price target on shares of Herbalife from $81.00 to $90.00 in a research note to investors on Friday, December 27th. Finally, analysts at Janney Montgomery Scott reiterated a “fair value” rating on shares of Herbalife in a research note to investors on Tuesday, December 17th. They now have a $85.00 price target on the stock, up previously from $79.00. One analyst has rated the stock with a sell rating, two have given a hold rating and six have assigned a buy rating to the stock. The company has an average rating of “Buy” and an average price target of $86.79.
In other Herbalife news, Insider Shin-Shing Bosco Chiu sold 1,989 shares of Herbalife stock on the open market in a transaction dated Monday, December 23rd. The shares were sold at an average price of $80.81, for a total transaction of $160,731.09. Following the sale, the insider now directly owns 6,177 shares of the company’s stock, valued at approximately $499,163. The transaction was disclosed in a document filed with the SEC, which is available at this link.
Herbalife Ltd. is a global network marketing company that sells weight management, nutritional supplements, energy, sports and fitness products and personal care products through a network of approximately 2.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.